10 sources checked · 2 source groups included · 2h ago
Still Watching
FDA approves landmark pancreatic cancer drug that's shown to improve survival
ABC News - Business and The Columbian (Vancouver WA) describe the same event in different terms.
3 Left7 Center0 Right
Still watching.Optics is waiting for a cleaner match before calling the split.
STILL WATCHING
As of August 27, 2026 at 1:17 AM, this is how Optics News reads the wording differences in this story.
What happenedThe drug uses a new approach to block a protein that fuels tumor growth. Patients taking the drug nearly doubled their survival time in a company study.
The headline splitThe left frames it as "FDA approves new pancreatic cancer drug that could extend patients' lives". The center frames it as "US drug agency approves breakthrough treatment for pancreatic cancer".
Match confidenceMedium confidence. 10 sources across 2 bias buckets. Useful framing signal — check the source list before sharing.
Same-event confidenceMedium
10 sources across 2 bias buckets agree on the event.
Framing confidenceModerate
58/99 — meaningful wording shift across the spectrum.
WHAT EACH SIDE EMPHASIZED
Left / center-leftFDA approves new pancreatic cancer drug that could extend patients' lives
CBS News · Center-left · News report
CenterFDA approves landmark pancreatic cancer drug that's shown to improve survival
WBIR10 (Tegna, Knoxville) · Center · News report
Right / center-rightNo matching source in this bucket yet.
FDA approves landmark pancreatic cancer drug that's shown to improve survival
The drug uses a new approach to block a protein that fuels tumor growth. Patients taking the drug nearly doubled their survival time in a company study.
FDA approves new pancreatic cancer drug that could extend patients' lives
Patients taking the first-of-a-kind pill, called daraxonrasib, lived for a median of 13.2 months compared with 6.7 months for chemotherapy recipients, studies showed.
FDA approves groundbreaking new pancreatic cancer drug
The Food and Drug Administration (FDA) on Wednesday approved a treatment for advanced pancreatic cancer, offering new life-extending care for patients with one of the most aggressive forms...
FDA approves new drug Rasonque to treat advanced pancreatic cancer
The US FDA on Wednesday approved Revolution Medicines' Rasonque for advanced pancreatic cancer, opening a new treatment option for patients with metastatic disease. A large trial found the...
Jerrty Simonson is shown at his home earlier this year in West Valley City, Utah. Simonson has been taking daraxsonrasib as part of a clinical trial for nearly four years. His cancer is no...
WASHINGTON — The Food and Drug Administration on Wednesday approved a groundbreaking new drug for advanced pancreatic cancer, offering U.S. patients a more effective treatment against one o...
